+

WO2006017353A3 - Traitement d'infections virales - Google Patents

Traitement d'infections virales Download PDF

Info

Publication number
WO2006017353A3
WO2006017353A3 PCT/US2005/024922 US2005024922W WO2006017353A3 WO 2006017353 A3 WO2006017353 A3 WO 2006017353A3 US 2005024922 W US2005024922 W US 2005024922W WO 2006017353 A3 WO2006017353 A3 WO 2006017353A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
viral infections
medicaments
pyrimidine
infected
Prior art date
Application number
PCT/US2005/024922
Other languages
English (en)
Other versions
WO2006017353A2 (fr
Inventor
Steven Zeichner
Vyjayanthi Krishnan
Original Assignee
Ices The Secretary Dept Of Hea
Steven Zeichner
Vyjayanthi Krishnan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ices The Secretary Dept Of Hea, Steven Zeichner, Vyjayanthi Krishnan filed Critical Ices The Secretary Dept Of Hea
Publication of WO2006017353A2 publication Critical patent/WO2006017353A2/fr
Publication of WO2006017353A3 publication Critical patent/WO2006017353A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Traitement de cellules ou d'humains porteurs d'un virus, ou infectés par ce dernier, capable de provoquer une maladie immunodéficitaire, au moyen de composés définis, y compris des dérivés de N-phényl-2-pyrimidine-amine représentés par la formule (I), dont les substituants sont indiqués dans le descriptif, et de médicaments contenant ces composés et leurs utilisations.
PCT/US2005/024922 2004-07-13 2005-07-13 Traitement d'infections virales WO2006017353A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58801504P 2004-07-13 2004-07-13
US60/588,015 2004-07-13

Publications (2)

Publication Number Publication Date
WO2006017353A2 WO2006017353A2 (fr) 2006-02-16
WO2006017353A3 true WO2006017353A3 (fr) 2006-03-30

Family

ID=35462172

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/024922 WO2006017353A2 (fr) 2004-07-13 2005-07-13 Traitement d'infections virales

Country Status (1)

Country Link
WO (1) WO2006017353A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008124129A2 (fr) * 2007-04-09 2008-10-16 University Of Massachusetts Procédés de traitement du vih
EP2152079A4 (fr) 2007-06-04 2011-03-09 Avila Therapeutics Inc Composés hétérocycliques et utilisations de ceux-ci

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0931544A2 (fr) * 1997-12-22 1999-07-28 Kaken Shoyaku Co., Ltd. Inhibiteur de l'activité NF-kB
US20040102453A1 (en) * 2000-09-13 2004-05-27 Buerger Hans Michael N-phenyl-2-pyrimidine-amine derivatives
US20040126877A1 (en) * 2001-04-20 2004-07-01 Man-Wook Hur Repressors for hiv transcription and methods thereof
WO2005072826A2 (fr) * 2004-01-21 2005-08-11 Emory University Compositions et procedes pour utiliser des inhibiteurs de tyrosine kinase afin de traiter une infection pathogenique

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0931544A2 (fr) * 1997-12-22 1999-07-28 Kaken Shoyaku Co., Ltd. Inhibiteur de l'activité NF-kB
US20040102453A1 (en) * 2000-09-13 2004-05-27 Buerger Hans Michael N-phenyl-2-pyrimidine-amine derivatives
US20040126877A1 (en) * 2001-04-20 2004-07-01 Man-Wook Hur Repressors for hiv transcription and methods thereof
WO2005072826A2 (fr) * 2004-01-21 2005-08-11 Emory University Compositions et procedes pour utiliser des inhibiteurs de tyrosine kinase afin de traiter une infection pathogenique

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BASKARAN RAJASEKARAN ET AL: "Nuclear c-Abl is a COOH-terminal repeated domain (CTD)-tyrosine kinase-specific for the mammalian RNA polymerase II: Possible role in transcription elongation", CELL GROWTH AND DIFFERENTIATION, vol. 10, no. 6, June 1999 (1999-06-01), pages 387 - 396, XP002361028, ISSN: 1044-9523 *
TSIMBERIDOU APOSTOLIA-MARIA ET AL: "Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: complete cytogenetic response with imatinib mesylate: report of a case and review of the literature", LEUKEMIA RESEARCH, vol. 28, no. 6, June 2004 (2004-06-01), pages 657 - 660, XP002361027, ISSN: 0145-2126 *

Also Published As

Publication number Publication date
WO2006017353A2 (fr) 2006-02-16

Similar Documents

Publication Publication Date Title
WO2007041487A3 (fr) Peptides inhibiteurs d&#39;infections virales
NZ609146A (en) Modified 4’-nucleosides as antiviral agents
WO2008127364A3 (fr) Composés antiviraux et utilisation de ceux-ci
MX2008001402A (es) Inhibidores macrociclicos del virus de la hepatitis c.
NZ585226A (en) Inhibitors of human immunodeficiency virus replication
WO2008045238A3 (fr) Peptides antiviraux hélicoïdaux courts thérapeutiques stabilisés
WO2010084115A3 (fr) Agents antiviraux
CA2862755A1 (fr) Composes antiviraux avec une fraction dibenzooxaheterocycle
WO2007029029A3 (fr) Derives d&#39;indole tetracycliques utilises comme agents antiviraux
WO2006046039A3 (fr) Derives d&#39;indole tetracycliques utilises comme agents antiviraux
WO2006124861A3 (fr) Composes de benzofuranne
TW200800969A (en) Compounds
ATE373005T1 (de) Thienopyrrole als antivirale mittel
WO2008069917A3 (fr) Nouveaux peptides cycliques
WO2005084192A3 (fr) Nouveaux derives nucleosidiques de 2&#39;-c-methyle
AU2003216934A1 (en) Benzoxazinone derivatives, the preparation and use thereof as medicaments
WO2006072347A3 (fr) Thiophene substitue par un alkinyle
WO2006072458A3 (fr) Derives d&#39;oxindol substitues, agents pharmaceutiques les contenant, et leur utilisation
WO2007065007A3 (fr) Traitement d&#39;infections virales
DK2025750T3 (da) Targets og forbindelser til terapeutisk intervention af HIV-infektion
WO2006033709A8 (fr) Nouveaux derives de nucleosides
WO2008043791A3 (fr) Composés
WO2006072348A3 (fr) Thiophene substitue par un alkinyle
WO2007018941A3 (fr) Composes
NO20074167L (no) Peptidiske forbindelser

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载